Iowa readers may be interested to learn that Veracyte recently expanded an early access program that uses the Envisia Genomic Classifier test to screen patients for idiopathic pulmonary fibrosis, or IPF. The test is currently offered in 20 medical centers in 12...
Program offering Envisia Genomic Classifier IPF test expanded
read more